Memo for opiod settlement - 10.29.26
Extracted text (via pymupdf_layout)
9696 characters
Timothy A. La Sota, PLC
2810 North 3rd Street
Phoenix, Arizona 85004
P 602-515-2649
tim@timlasota.com
October 29, 2026
MEMORANDUM
To: Rachael Goodwin, Fountain Hills Town Manager
Cc: Paul Soldinger, Fountain Hills Chief Financial Officer
From: Timothy A. La Sota, Fountain Hills Town Attorney
Re: Summary of Albertsons Companies, Inc. Settlement Terms and Settlement
Participation and Release Form
On or about October 21, 2026, the Town of Fountain Hills ("Town") received notice
from the National Opioid Settlements Implementation Administrator that a new nationwide
settlement agreement had been reached with Albertsons Companies, Inc. (Albertsons)
concerning alleged misconduct related to opioids. See Exhibit A
This Memo is intended to provide the Town with an overview of the settlement terms
and the steps necessary to participate in the Albertsons Agreement.
Background
In 2021, Arizona participated in national opioid settlements with J&J and Distributors
McKesson, Cardinal Health, and AmerisourceBergen ("2021 National Settlements"). In
2022, five additional Defendants - Teva, Allergan, Walmart, Walgreens and CVS - agreed to
enter into settlement agreements ("2022 National Settlements"). In 2024, the Kroger
Company agreed to enter into a settlement agreement ("2024 Kroger Settlement"). The Town
participated in all of these settlement agreements. Settlement monies are allocated to the
County and then distributed to the Town who allocates the funds in accordance with the One
Arizona Distribution of Opioid Settlement Funds Agreement ("One Arizona Funds
Agreement").
As of April of 2026, Albertsons Companies, Inc. (Albertsons) has agreed to settle
opioid-related lawsuits with the eligible states (including Arizona), and the Town has the
opportunity to once again participate, benefiting from the proceeds of these settlements
through the One Arizona Funds Agreement.
Town Participation in the Albertsons Agreement
A Notice was sent by email from opioidsparticipation@rubris.com on or about
October 21, 2026 providing notice of the Settlement Agreement and the deadline to
participate in the Direct Settlement. See Exhibit A.
To participate in the Albertsons Agreement and obtain proceeds from the Direct
Settlement, the Town must execute and submit a Subdivision Participation and Release Form
("Participation Form") before December 30, 2026.
By signing the Participation Form, the Town agrees to the terms of the Albertsons
Settlement and forever waives any right to file suit against Albertsons for any opioid-related
claim.
Settlement Funds
As of August of 2026, the maximum payment to be distributed to Arizona under the
Albertsons Agreement is estimated to be over $18 million over nine years. However, the
actual amount that will be distributed depends on the level of participation by eligible states
and subdivisions. The amount distributed to the Town of Fountains Hills will be determined
at a later date when allocated funds to Maricopa County are finalized.
The Arizona Attorney General's Office has confirmed that distribution will occur in
the same manner as previous opioid settlements pursuant to the One Arizona Funds
Agreement with the counties receiving the regional funds and distributing the monies to
participating cities and towns. Distribution is based on population figures published by the
U.S. Census Bureau's population estimates for July 1, 2019, released May 2020.
Similar to the previous settlements, the settlement funds must be used in connection
with future opioid-remediation efforts including care, treatment and other programs and
expenditures designed to address the misuse and abuse of opioid products; treat or mitigate
opioid use or related disorders; or mitigate other alleged effects of the opioid epidemic.
Further, under the One Arizona Funds Agreement, participating in the Albertsons
Settlement requires the Town to provide regular reporting to demonstrate all settlement funds
are being allocated to opioid-remediation efforts.
The Town has already accepted multiple similar settlements, so I can think of no
reason not to accept this one.
Next Steps
1. Because the Town has previously approved a motion to "take all necessary steps to
finalize opioid settlements, including... any future settlement or other agreements"
(see Exhibit B), the Albertsons Agreement has been placed on the November 17,
2026 consent agenda to affirm the Council's prior authorization. The full
Albertsons Agreement and related documents are on file with the Town Clerk.
2. If the Council approves opting in to the Albertsons Agreement, signing
instructions will be sent and the appropriate persons will sign for the Town.
3. Once the settlement is finalized, the release against Albertsons will be in effect.
4. The Town will be notified when the funds are available, and the Town can then
request its proportional share of the settlement funds for use in accordance with
the One Arizona Funds Agreement.
Exhibit A
National Opioids Settlement: Albertsons
Opioids Implementation
Administrator
opioidsparticipation@rubris.com
Fountain Hills town, AZ
Reference Number: CL-2262205
TO LOCAL POLITICAL SUBDIVISIONS AND SPECIAL DISTRICTS:
THIS NOTICE CONTAINS IMPORTANT INFORMATION ABOUT A NEW NATIONAL
OPIOID SETTLEMENT.
SETTLEMENT OVERVIEW
A proposed settlement agreement (“Settlement”) has been reached between regional
supermarket pharmacy Albertsons Companies, Inc. and thirty-four states and the District of
Columbia. The Settlement would resolve the legal claims of states and local political
subdivisions against Albertsons for alleged misconduct related to the distribution and
dispensing of opioids. Pursuant to the terms of the Settlement, Albertsons has determined that
enough eligible states have agreed to join the Settlement to proceed with notice to
subdivisions.
The Settlement requires Albertsons Companies, Inc. to pay over $770 million. Of this amount,
approximately $655 million will be used by participating states and subdivisions to remediate
and abate the impacts of the opioid crisis. The Settlement requires payments over 9 years.
The Settlement also contains injunctive relief governing opioid dispensing practices and
requires Albertsons to implement safeguards to prevent diversion of prescription
opioids.
The proposed Settlement has two key participation steps:
First, each eligible state decides whether to participate in the Settlement. A list of participating
states can be found at https://nationalopioidsettlement.com/state-participation-status/
Second, eligible subdivisions within each participating state decide whether to participate in the
Settlement. The more subdivisions that participate, the more funds flow to that state and its
subdivisions. Any subdivision that does not participate cannot directly share in any of the
settlement funds, even if the subdivision’s state is settling and other participating subdivisions
are sharing in settlement funds. If the state does not participate, the subdivisions in that state
are not eligible to participate in the Settlement.
Eligible Entities must decide whether to participate by December 30, 2026.
WHO IS RUBRIS INC. AND WHAT IS THE IMPLEMENTATION ADMINISTRATOR?
The Settlement provides that an Implementation Administrator will provide notice and
manage the collection of participation forms. Rubris, Inc. is the Implementation Administrator
for this
new Settlement and was also retained for the prior national opioid settlements.
WHY IS YOUR ENTITY RECEIVING THIS NOTICE?
Your entity is eligible to participate in this Settlement. This Notice is also sent directly to
counsel for each Eligible Entity if the Implementation Administrator has their information.
If you are represented by an attorney with respect to opioid claims, please contact
them. Subdivisions can participate in this Settlement whether or not they filed a
lawsuit or are represented.
WHERE CAN YOU FIND MORE INFORMATION?
Detailed information about the Settlement may be found at:
https://nationalopioidsettlement.com
You are encouraged to review the Settlement Agreement terms and discuss the terms
and benefits with your counsel. Each Eligible Entity will need to decide whether to participate
in the proposed Settlement, and entities are encouraged to work through this process
before the December 30, 2026 deadline.
You are encouraged to review the settlement agreement terms and discuss the terms
and benefits with your counsel, your Attorney General’s Office, and other contacts
within your state. Information and documents regarding the Settlement and your state
allocation can be found on the settlement website at
https://nationalopioidsettlement.com/.
Your subdivision will need to decide whether to participate in the proposed
Settlement, and subdivisions are encouraged to work through this process before the
December 30, 2026 deadline.
HOW DO YOU PARTICIPATE IN THE SETTLEMENT?
The Settlement requires that each Eligible Entity take affirmative steps to “opt in” to
the Settlement. You will receive the Subdivision Participation and Release Form via Docusign
along with instructions from the Implementation Administrator. In order to participate
in this Settlement, a person with authority must sign and return the required
Subdivision Participation and Release Form. Docusign remains the preferred method of
submission of the needed form.
Please add the following email addresses to your “safe” list so emails do not go to spam / junk
folders: dse_na3@docusign.net and opioidsparticipation@rubris.com. Please monitor your
email for the Participation Form and instructions.
All required documentation must be signed and returned on or before December 30, 2026.
Exhibit B